New Research Report On Global Anti-Migraine Drugs Market 2014 Trends and Opportunities upto 2019
The report titled “Global Anti-Migraine Drugs Market: Trends and Opportunities (2014-2019)” provides an insight into migraine drugs with a special focus on Triptans. The report also includes the market value, segmentation, types of diagnosis and treatment for migraine. It also discusses key growth drivers and upcoming trends of the market. Further, key manufacturers of anti-migraine drugs like Endo International Inc, Imapc Laboratories, GlaxoSmithKline and Pfizer Inc. are profiled in the report.
Segments Coverage
Triptans
Ergot Alkaloids
Company Coverage
Endo International Inc.
IMPAX Laboratories Inc.
GlaxoSmith Kline (GSK)
Pfizer Inc.
Download free Sample PDF report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=207524
Executive Summary
Migraine, a condition of recurring headaches and is accompanied by symptoms like nausea, vomiting, dizziness and sensitivity to light and noise ranks among the World’s Top 20 disabling medical illnesses. It is anticipated that launches of many generic migraine drugs over the next several years will steadily increase diagnosis and drug-treatment rates, leading to sustained annual global growth of anti-migraine drugs market. Other factors contributing to the growth of these drugs include awareness among the people about proper diagnosis and treatment of migraine, rise in medical expenditures and new drugs launches.
Acute migraine treatment market is dominant by Triptans and most of them are available as pills. Triptans like Sumatriptan and Zolmitriptan are also available as nasal sprays whereas rizatriptan and zolmitriptan are available as tablets that dissolve in mouth. In next 5-10 years, cost of migraine drugs is anticipated to decline due to many generic entrants as most of them are losing their patents. Growing awareness of migraine in the emerging countries and fall in prices will facilitate the growth of anti-migraine drugs market. In addition, with the development of new treatment therapies like calcitonin gene-related peptides (CGRP) receptor antagonist and BOTOX the demand for anti-migraine drugs is anticipated to grow further.
Read All Pharmaceutical Market Research Reports @ http://www.researchmoz.us/pharmaceutical-market-reports-38.html
Table of Content
1. Executive Summary
2. Migraine
2.1 An Overview
2.2 Different Types of Migraines
2.2.1 Migraine without Aura
2.2.2 Migraine with Aura
2.2.3 Other Types of Migraine
2.3 Diagnosis and Treatment
3. Anti-Migraine Drugs Market
3.1 Global Anti-Migraine Drugs Market Size (2009-2013)
3.2 Forecast- Global Anti-Migraine Drugs Market Size (2014-2019)
3.3 Segmentation by Type of Drugs Used
3.4 Migraine Specific Drugs
3.4.1 Triptan
Types of Triptans
Effectiveness of Triptans
Triptan Costs
3.4.2 Tezampanel
3.4.3 Ergots Alkaloids
3.5 Prevalence of Migraine
About ResearchMoz
ResearchMoz is the worlds fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMozs service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:
Mr. Nachiket
Albany NY - 12207
United States
Tel: +1-518-621-2074
Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG